E, P., E, C., J, D., C, P., D, H., P, R., . . . J, O. (2024). Impact of MYC and BCL2 double expression on outcomes in primary CNS lymphoma: A UK multicenter analysis. Blood advances, 8(7), 1772. https://doi.org/10.1182/bloodadvances.2023011426
Chicago Style (17th ed.) CitationE, Poynton, et al. "Impact of MYC and BCL2 Double Expression on Outcomes in Primary CNS Lymphoma: A UK Multicenter Analysis." Blood Advances 8, no. 7 (2024): 1772. https://doi.org/10.1182/bloodadvances.2023011426.
MLA (9th ed.) CitationE, Poynton, et al. "Impact of MYC and BCL2 Double Expression on Outcomes in Primary CNS Lymphoma: A UK Multicenter Analysis." Blood Advances, vol. 8, no. 7, 2024, p. 1772, https://doi.org/10.1182/bloodadvances.2023011426.
Warning: These citations may not always be 100% accurate.